Advertise on podcast: Psychedelic Insiders

On this episode of Psychedelic Insiders, Najla Guthrie, CEO of KGK Science opens up about her 25 years experience in straightening out the wild field of natural medicines. She talks to Jason Najum about her business experience, how to go about drug development the right way, various regulatory bodies, and more. PSYCHEDELIC INSIDERS Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company. LINKS: Video of interview: https://youtu.be/XJL1FKmi4JI www.kgkscience.com www.microdose.buzz

Robin Arnott has been studying ways of invoking psychedelic experiences through technology. Jason Najum goes deep into the nebulous realm of possible human experiences. Watch the live video interview at: https://youtu.be/p_coZ3pZ-wQ PSYCHEDELIC INSIDERS Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company. https://my.captivate.fm/www.microdose.buzz (www.microdose.buzz)

Episode 10 - July 15th 2020 Natasha de Jong - Co-Founder and CEO at https://earthresonance.bio/ (Earth Resonance) Presented by https://www.paulaustin.co/ (Paul Austin) of https://thethirdwave.co/ (The Third Wave) Earth Resonance Natasha de Jong is the co-founder and CEO of Earth Resonance. With Earth Resonance, we are the no1. microdosing company for personal, spiritual and therapeutical transformation. Earth Resonance believes in medicine from the Earth, not from a lab. That is why we take an integrated approach. With our protocols, therapists and healing fungi, we raise your frequency naturally and offer life changing tools which supports this transformational process. Earth Resonance is located in the Netherlands and work together with industry leaders with more than 20 years of experience in the field of cultivating fresh psychedelic sclerotia. The company is proud to share with you their journey, testimonials of transformation and are looking forward to speak to you about the revolution of consciousness with psychedelics, botanicals and healing frequencies. PSYCHEDELIC INSIDERS Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company.

Episode 6 - June 17th 2020 Danny Motyka - CEO of https://www.psygen.ca/ (Psygen) Presented by https://thethirdwave.co/ (Paul Austin) of https://thethirdwave.co/ (Third Wave) Psygen Psygen is a manufacturer of pharmaceutical-grade psychedelic drug products for clinical research and therapeutic applications. Danny Motyka has long been a proponent of psychedelic medicine. Personal experience with psilocybin and LSD helped him understand and manage major depression, and ultimately inspired him to dedicate his attention to psychedelic medicinal chemistry. After graduating from the University of Victoria with an honours degree in chemistry, he began his rise through management at Aurora Cannabis. His career with Aurora included multiple years as General Manager of a cannabis cultivation and processing facility, providing foundational experience with the intricacies of good manufacturing practices, and a strong knowledge of the Controlled Drugs and Substances Act and the associated regulations. PSYCHEDELIC INSIDERS Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company.

Episode 3 - May 27th 2020 Susan Chapelle - Co-CEO at HAVN Life Presented by https://alanaldous.com/ (Alana Armstrong) HAVN LIFE HAVN is creating standardized formulas using psychoactive compounds for scientific research and natural health care products for human performance. PSYCHEDELIC INSIDERS Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company.

On this episode of Psychedelic Insiders, Doug Drysdale, CEO of Cybin Inc. powers through a cold to share some insights on the present and future of psychedelic medicine. He talks to Microdose's Jason Najum about psychedelic drug development, mental health therapies involving psychedelics, and more. PSYCHEDELIC INSIDERS Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company. LINKS: Video of interview: https://youtu.be/7AfG58q-KGw www.cybin.com www.microdose.buzz Subscribe today! on Apple Podcasts: https://podcasts.apple.com/us/podcast/psychedelic-insiders/id1531628901 on Spotify: https://open.spotify.com/show/3Nyc58Ov7GYBeeLcWheBSx on Youtube: https://www.youtube.com/playlist?list=PLMj79P4l-kSl5YY6VA9mbkOxQPDrM5NE1

On this episode of Psychedelic Insiders, Jeeshan Chowdhury, Co-Founder and CEO of Journey CoLab opens up about his intentional path set for the company, using mescaline as medicine to combat endemic addictions like Alcohol Use Disorder. He talks to Jason Najum about drug development, psychedelic mental health care, and more. PSYCHEDELIC INSIDERS Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company. LINKS: Video of interview: https://youtu.be/qq2wCyJ3aCc www.journeycolab.com www.microdose.buzz Subscribe today! on Apple Podcasts: https://podcasts.apple.com/us/podcast/psychedelic-insiders/id1531628901 on Spotify: https://open.spotify.com/show/3Nyc58Ov7GYBeeLcWheBSx on Youtube: https://www.youtube.com/playlist?list=PLMj79P4l-kSl5YY6VA9mbkOxQPDrM5NE1

Janet talks about her mission to pursue breakthrough medicines via her company PurMinds Biopharma. She talks to Jason Najum about her business experience, ALS, data science, drug development, neuroscience, the FDA, and more. PSYCHEDELIC INSIDERS Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company. LINKS: www.purminds.com www.microdose.buzz Subscribe to the Playlist: https://www.youtube.com/playlist?list=PLMj79P4l-kSl5YY6VA9mbkOxQPDrM5NE1 Hashtags: #PurMinds #FemaleCEO #BioPharma #JanetQi #MentalHealth #ALS #Psychedelics #Psychedelia #Health #Medicine #Healing #Pharmaceuticals #DrugDevelopment #ClinicalTrials

“Everyday is psychedelic”, that’s the motto of Psychedelic Water, the world’s first legal psychedelic beverage.Microdose writer Jason Najum sat down with Psychedelic Water CEO Pankaj Gojia to discuss the company's mission and product. PSYCHEDELIC INSIDERS Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company. LINKS: VIDEO VERSION: https://youtu.be/kQA-Oemyy-Q www.psychedelicwater.com www.microdose.buzz

Matthew Johnson, graced by the psychedelic Gods with regulatory approval and grants from the US Federal government, has been studying psychedelics with fervour as they are his pharmacological passion. Jason Najum of Microdose Psychedelic Insights takes us on a wild ride of an interview that may or may not end in Jason's microdose turning him into a cat. PSYCHEDELIC INSIDERS Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company. https://my.captivate.fm/www.microdose.buzz (www.microdose.buzz) Matthew JohnsonSusan Hill Ward Professor of Psychedelics and Consciousness Johns Hopkins University School of Medicine Matthew W. Johnson, Ph.D., is The Susan Hill Ward Endowed Professor of Psychedelics and Consciousness Research at Johns Hopkins University School of Medicine. Working with psychedelics since 2004, he is one of the world’s most widely published experts on psychedelics. He has published over 150 scientific papers, including psychedelic safety guidelines (2008) that helped to resurrect human psychedelic research, first research on psychedelic treatment of tobacco addiction (2014), and studies of psilocybin in cancer-related distress (2016) and depression (2020). His psilocybin review recommended Schedule IV upon potential medical approval (2018). Matt also conducts behavioral economic research on the psychology of addiction and sexual risk. He is a past President of the Psychopharmacology and Substance Abuse Division of the American Psychological Association, and current President of the International Society for Research on Psychedelics. In 2021 Matt received as principal investigator the first grant awarded by the US government in 50 years for a treatment trial of a classic psychedelic (psilocybin for smoking cessation). He has been interviewed by Anderson Cooper on 60 Minutes, the New York Times, the Washington Post, the Wall Street Journal, the BBC, CNN, Fox Business News, NPR, and in Michael Pollan’s book How to Change Your Mind. Twitter: @Drug_Researcher

In support of fellow advocates and entrepreneurs in the psychedelic medicine space, Mircrodose sat down with the team behind the "Psychedelic Frontiers Virtual Summit". The virtual conference is taking place this weekend and will feature interviews with over 40 leading experts in the field. The event is free to attend. Check it out at: https://www.psychedelicfrontiers.ca/ (www.psychedelicfrontiers.ca) PSYCHEDELIC INSIDERS Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company. www.microdose.buzz

Microdose's Jason Najum sat down with Field Trip founder Ronan Levy to discuss the NASDAQ, new molecules, and how to bring magic and poetry to the business world. PSYCHEDELIC INSIDERS Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company. Ronan Levy, Executive Chairman and Co-Founder, Field Trip Health Co-founder of Field Trip Psychedelics, a partner at Grassfed Ventures, a venture capital and advisory firm focused on the cannabis and biotech industries and a director for Trait Biosciences Inc. www.microdose.buzz